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Most cases of hydronephrosis are caused by urinary tract
obstruction. However, excessive polyuric syndrome rarely
gives rise to non-obstructive hydronephrosis, megaureter, and
a distended bladder. The authors report here on two cases of
congenital nephrogenic diabetes insipidus (NDI) with severe
bilateral hydronephrosis and megaureter. It is Interesting that
the patients were symptomless except for their polyuria, and
they both presented with bilateral hydronephrosis. Fluid depri-
vation testing revealed the presence of AVP resistant NDI.
Gene analysis for these patients showed the AVP receptor 2
(V2R) missense mutations (Q225X and S126F), which have
previously been reported on in other studies. We made the
diagnosis of NDI by using a physiologic test, and we con-
firmed it by mutation analysis of the V2R gene.
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INTRODUCTION
Nephrogenic diabetes insipidus (NDI) is a dis-
order that is inherited or acquired, and it is char-
acterized by the loss of the ability to concentrate
urine, and the insensitivity to arginine vasopressin
(AVP).
1
Most cases of congenital NDI (> 90%) are
caused by a mutation in the AVP receptor 2 gene
(V2R), and this is inherited as a X-linked recessive
trait. The remaining cases are caused by mutation
in the aquaporin 2 (AQP2) water channel gene
with an autosomal recessive or dominant inheri-
tance pattern.1-3 Patients with congenital NDI
present in infancy or childhood with the various
clinical symptoms of polyuria and polydipsia, and
there are rare long-term sequelae such as growth
retardation and urologic complications.4 Urologic
problems in NDI have been reported as ranging
from mild dilatation of ureter to severe hydro-
nephrosis with neurogenic bladder.5,6 The diag-
nosis of congenital NDI with hydronephrosis is
often confused due to this disease's similarity with
acquired NDI of postobstuctive uropathy7-10 and
the relatively rare incidence of congenital NDI
that presents with hydronephrosis. Molecular
analysis would be a useful diagnostic method,
particularly for the unusual clinical presentation
of congenital NDI. In this study, we describe two
congenital NDI patients with mutations in the
V2R gene and severe hydronephrosis.
CASE REPORT
Case 1
A 20-year-old man was admitted to Yonsei
Medical Center, Seoul, Korea, because of the
polyuria he had suffered from for several years.
He has experienced polyuric symptom since child-
hood, however, he did not receive any specific
evaluation except for intermittent medication for
enuresis. On physical examination, he had nor-
mal blood pressure and no growth failure. His
urine volume was more than 5,000 mL per day.
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His blood laboratory results were: serum Na+
145 mEq/L, Cl- 106 mEq/L, K+ 3.8 mEq/L, tCO2
27 mEq/L, BUN 7.9 mg/dL, and creatinine 1.1
mg/dL. The urinalysis was normal except for the
low specific gravity (< 1.003). Serum and urine
osmolality were 302 and 96 mOsm/kg H2O, re-
spectively. An intravenous pyelogram and CT re-
vealed a markedly distended bladder and bilateral
hydronephrosis without any obstructive lesion of
the ureter or urethra (Fig. 1A and 1B).
Case 2
A 21-year-old military soldier was admitted to
the Armed Forces Capital Hospital because of
maladaptation to the military services. He has had
hard time coping in the military services due to
his polyuria and nocturia that occurred everyday.
He has urinated every 1 hour for several years,
but, no specific evaluation or treatment had ever
been done. On physical examination, he had
normal blood pressure and a normal growth de-
velopment. His urine volume was more than
10,000 mL per day. His blood laboratory results
were: serum Na
+
154 mEq/L, Cl
-
108 mEq/L, K
+
2.9 mEq/L, tCO2 30 mEq/L, BUN 17.1 mg/dL,
and creatinine 1.6 mg/dL. The urinalysis was nor-
mal except for the low specific gravity (<1.003).
The serum and urine osmolality were 303 and 87
mOsm/kg H2O, respectively. Abdomino-pelvic
CT showed a markedly distended bladder, bilat-
eral hydroureter, and hydronephrosis without any
organic obstruction (Fig. 1C).
Fluid deprivation test with AVP responsiveness
The patients stopped all medications for at least
a week before the studies. Fluid deprivation test
was performed with the study protocol being as
described previously.11
Genomic DNA isolation from blood and PCR
DNA extraction from the whole blood was per-
Fig. 1. X-ray findings of the two patients. Intravenous pyelogram (A) and abdomino-pelvic CT (B) of case 1 showing
the marked bilateral dilatation of the ureter and calyceopelvic system. Abdominal CT scan (C) of case 2 revealing
bilateral hydronephrosis. The bladder is markedly enlarged with severe trabeculation.
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formed by using a Qiagen DNA mini kit (Qiagen
Inc., Valencua, CA, U.S.A.). Four pairs of oligonu-
cleotide primers were designed to allow the
amplification of all three exons in the V2R gene
(Table 1). PCR was performed using genomic
DNA 100 ng, 1U of Taq polymerase, 0.4 uM each
of the sense and antisense primers, 1.5 mM MgCl2
and 20 mol/L dNTP in a volume of 50μ L con-
taining 1 × PCR buffer. The PCR conditions used
were as follows (Table 1): Initial heating at 95
for 9 minutes, and this was followed by 35 cycles
of denaturation at 95 for 45 seconds, annealing
at the corresponding temperature for 45 seconds,
and extension at 72 for 1 minute. And a final
extension step at 72 for 7 minutes was per-
formed. The PCR products were confirmed by
ethidium bromide staining after electrophoresis in
2% agarose gel, and desired spots were cut out of
the gel with a razor blade for DNA sequence
analysis.
DNA sequence analysis
The PCR products were purified using a DNA
purification kit (PCRquick-spin, Intron, Sungnam,
Kyungki-do, Korea). Sequencing was preformed
by the cycle sequence method with a DNA Se-
quencing Kit (Applied Biosystems, Foster city,
CA, U.S.A.) in a thermal cycler (PCR 9600,
Applied Biosystems, U.S.A.).
Fluid deprivation test
The ability to concentrate urine was impaired
for both case 1 and 2 patients despite of the in-
crease in serum osmolality. In addition, the
urine osmolality remained below 100 mOsm/kg
H2O even after desmopressin administration
(Table 2).
Table 2. Results of Water Deprivation Tests in Two Patients
Case 1 Case 2
S-Osm U-Osm S-Osm U-Osm
8 AM 291 76 291 42
10 AM 291 93 303 48
MD 299 90 302 47
IV AVP injection
After 1 hour 302 97 51
After 2 hour 299 85 302 68
After 4 hour 297 90 296 48
MD, midday; S-Osm, serum osmolality (mOsm/kg H2O); U-Osm, urine osmolality (mOsm/kg H2O); AVP, desmopressin
acetate 4μg.
Table 1. Primer Sequences and PCR Conditions
Primers Sequences Annealing temperature ( )
Primer 1
(3-113 bp)
TGCTCCTCAGGCAGAGGCTGA
ACTCTGCCCACCGGACTCATG
60
Primer 2
(411-1144 bp)
TGCACAGCACCCTCTCTAACC
GCACCAGACTGGCATGAATCT
62
Primer 3
(865-1376 bp)
ATGCTGGCGTACCGCCATGGA
TGGCCCCGTCAGCCCTAGCCA
58
Primer 4
(1425-1690 bp)
AACCTAGATCCTCCACTCCCA
CTCAAAGCCTCTAGAGGCAAG
60
PCR, polymerase chain reaction.
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Identification of mutation in the V2R gene
Mutation analysis was performed on the V2R
gene of these patients. A missense mutation in
each patients was identified by direct sequencing
analysis (Fig. 2). In patient 1, a C to T transversion
resulted in an early termination at amino acid 225
(Q225X). For patient 2, one base substitution of C
for T was identified at the 809 nucleic acid in exon
2, which had Ser for Phe substituted at codon 126
(S126F).
DISCUSSION
While water permeability of the principal cells
in distal nephron is relatively low in the basal
state, AVP is secreted in response to various os-
molar or volume stimuli and it binds to the V2R
on the principal cells which leads to the move-
ment of AQP-2 water channels from the intracel-
lular vesicles into the apical plasma membrane,
resulting in the increase in the water permea-
bility.12,13 The mutations in the V2 receptor gene
or the AQP-2 water channel gene can induce resis-
tance to AVP which is a pathophysiologic charac-
teristic of NDI. Congenital NDI is mostly
inherited as an X-linked recessive trait that is
caused by V2R mutation, and in minor cases, it is
transmitted as an autosomal recessive form
caused by mutation in AQP2 water channel gene.
Although this disorder is caused by various
mutations and various inheritances, the
phenotypical features of the patients are identical.
In most cases, clinical symptoms with polyuria
usually begin within the first week of life, how-
ever, these features are often not recognized in
early infancy. In childhood or early adolescence,
the affected patients have recurrent episodes of
severe hypernatremia due to dehydration, and
they also have non-specific symptoms such as
anorexia, nausea, and fever. Unless this condition
is treated appropriately, the recurrent episodes of
dehydration can lead to growth disturbance and
mental retardation in severe cases.14,15 In addition,
there are urologic complications ranging from
mild ureter dilatation to severe hydronephrosis,
megaureter, and megabladder that develop due to
the large urine volume in patients with congenital
NDI.16-19
Differentiation of the congenital disease from
acquired NDI, which is caused by long-standing
neurogenic bladder or postobstuctive uropathy,
may be difficult, because both diseases are occa-
sionally accompanied with polyuria and hydrone-
phrosis.7,9,10 Therefore, a tentative diagnostic
methodology other than the clinical findings is
mandatory to confirm congenital NDI. Ever since
the V2R gene was cloned in 1992, gene mutation
analysis has become the best confirmative method
for congenital NDI.20,21 As a result, approximately
one hundred mutations in the V2R gene have
been reported in the literatures, however, there
has been no report on the V2R mutation for any
cases of Korean congenital NDI with hydrone-
phrosis. Hence, we report here on two Korean
patients with congenital NDI that presented with
bilateral hydronephrosis; one patient had the
Fig. 2. Missense mutation identified by direct sequencing
analysis in both case 1 and 2. The DNA chromatograms
are shown. (A, Case 1) C to T transition at nucleoside
position 1,105 results in a stop codon, leading to a
premature termination at the 225 aminoacid residues (Gln
225 Term). (B, Case 2) One base substitution of C for T
caused a substitution of Ser for Phe at the 126 amino acid
position (S126F).
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Q225X missense mutation and the other patient
had the S126F mutation.
It is obvious that the Q225X missense mutation
is responsible for causing the AVP unrespon-
siveness in the distal collecting tubule because the
mutation results in the premature termination of
the amino acid in V2R gene, and the mutated
products are short compared to the intact V2R.22
In addition, the S126F mutation has previously
been reported in Canadian patients,22 and this
may be one of the hot spots for nucleotide substi-
tutions. This amino-acid substitution probably in-
duces conformational changes of the V2R gene, re-
sulting in the loss of function of the V2R protein.
In conclusion, we report here on two cases of
congenital NDI with bilateral non-obstructive
hydronephrosis that were diagnosed by fluid depri-
vation tests and the diagnosis was confirmed by
V2R mutation analysis. Since the structural changes
of the urinary tract and growth retardation are
reversible when the treatment is initiated as soon as
possible, genetic counseling and evaluation for the
high-risk family members is highly recommended.
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